Your session is about to expire
← Back to Search
Procedure
Radiofrequency Neurotomy for Facetogenic Headache
N/A
Recruiting
Research Sponsored by Allevio Pain Management Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Two single blinded facet medial branch blocks (MBB) performed 30 days prior to the facet RF
Subjects show 50% and more pain relief after each MBB (using VAS for this assessment)
Must not have
Patients with coagulation issues, those currently using anticoagulants and didn't stop them based on Allevio clinic's policy for anticoagulants
Any pain interventions including previous RF, MBB, infusions 90 days prior to the first MBB for the same area (Except failed Botox injection, and trigger point injection)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks after rf and if the score was 12 or higher repeat monthly up to 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two treatments, PRF and CRF, which use electrical currents to reduce chronic neck pain by numbing the nerves. It targets patients with conditions like cervicogenic headache or occipital neuralgia who may not respond well to other treatments. Pulsed radiofrequency (PRF) was introduced as a non-destructive alternative to continuous radiofrequency (CRF) energy for treating chronic pain.
Who is the study for?
This trial is for adults aged 18-90 with chronic neck, shoulder pain or cervicogenic headaches lasting over 3 months. Participants must have had some relief from two medial branch blocks and not responded well to other treatments like medications or physical therapies. Pregnant individuals, non-English speakers, those who refuse consent, allergy sufferers, patients with coagulation issues on anticoagulants that can't be stopped as per clinic policy are excluded.
What is being tested?
The study compares Pulsed Radiofrequency Ablation (P-RF) against Continuous Radiofrequency Neurotomy (C-RF) in treating cervical facet joint-mediated pain. It aims to determine which method offers better pain control by reviewing previous studies where C-RF showed higher success rates than P-RF for conditions like trigeminal neuralgia and occipital neuralgia.
What are the potential side effects?
While the specific side effects of P-RF and C-RF aren't detailed here, radiofrequency ablation procedures may include temporary increased nerve pain, numbness or tingling near the injection site, infection risk at the needle insertion point, mild backache or discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had two specific spine injections 30 days before a spine procedure.
Select...
I experience over 50% pain relief after each medial branch block.
Select...
I am between 18 and 90 years old.
Select...
I am between 18 and 90 years old.
Select...
My pain has lasted for more than 3 months.
Select...
I have pain in my neck, shoulder, or headaches originating from my neck.
Select...
I have tried treatments like pain meds, massage, acupuncture without success or couldn't tolerate them.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have blood clotting issues and haven't stopped my anticoagulants as per clinic policy.
Select...
I haven't had pain treatments like RF or infusions for the same area in the last 90 days, except for Botox or trigger point injections.
Select...
I do not speak English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks after rf and if the score was 12 or higher repeat monthly up to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks after rf and if the score was 12 or higher repeat monthly up to 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Quality of life measurement: Neck Disability Index
Quality of life measurement: Short Form Brief Pain Inventory
Quality of life measurement: Visual Analogue Scale
Secondary study objectives
Adverse events
At least 30% Changes in Pain Score
At least 50% Changes in Pain Score
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Continuous Radiofrequency AblationActive Control1 Intervention
Radiofrequency ablation of sensory nerves at minimum 3 levels of cervical spine, burn will be made at 80° for 60 seconds.
Group II: Pulsed Radiofrequency AblationActive Control1 Intervention
Radiofrequency ablation of sensory nerves at minimum 3 levels of cervical spine with Maximum allowable temperature 50° rotation: 90.; Pulse rate: 3 Hz; pulse duration: 50 ms; 3 minutes
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Cervical Facet Radiofrequency (C-RF) works by applying heat generated through radiofrequency waves to nerve tissues, effectively ablating them to interrupt pain signals from reaching the brain. This method is particularly useful for chronic shoulder pain as it targets the specific nerves responsible for transmitting pain, providing significant and often long-lasting relief.
Other common treatments include physical therapy, which improves shoulder function and reduces pain through exercises that enhance strength and flexibility, and corticosteroid injections, which reduce inflammation and pain by delivering anti-inflammatory medication directly to the affected area. Understanding these mechanisms is crucial for chronic shoulder pain patients as it helps them and their healthcare providers choose the most appropriate treatment based on the underlying cause of their pain and their specific medical needs.
Manual treatment for cervicogenic headache and active trigger point in the sternocleidomastoid muscle: a pilot randomized clinical trial.Pulsed radiofrequency application in treatment of chronic zygapophyseal joint pain.Pulsed and continuous radiofrequency current adjacent to the cervical dorsal root ganglion of the rat induces late cellular activity in the dorsal horn.
Manual treatment for cervicogenic headache and active trigger point in the sternocleidomastoid muscle: a pilot randomized clinical trial.Pulsed radiofrequency application in treatment of chronic zygapophyseal joint pain.Pulsed and continuous radiofrequency current adjacent to the cervical dorsal root ganglion of the rat induces late cellular activity in the dorsal horn.
Find a Location
Who is running the clinical trial?
Allevio Pain Management ClinicLead Sponsor
3 Previous Clinical Trials
266 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had two specific spine injections 30 days before a spine procedure.I experience over 50% pain relief after each medial branch block.I have blood clotting issues and haven't stopped my anticoagulants as per clinic policy.I am between 18 and 90 years old.You are allergic to a specific medication or the contrast dye used in radiology tests.My pain medication dose has been stable for the last 4 weeks.I have tried various treatments for my condition without success or could not tolerate them.I haven't had pain treatments like RF or infusions for the same area in the last 90 days, except for Botox or trigger point injections.I am between 18 and 90 years old.My pain has lasted for more than 3 months.I have pain in my neck, shoulder, or headaches originating from my neck.I do not speak English.I have tried treatments like pain meds, massage, acupuncture without success or couldn't tolerate them.If you had a medical injection to relieve pain and it didn't help much (less than half) based on a pain scale.
Research Study Groups:
This trial has the following groups:- Group 1: Continuous Radiofrequency Ablation
- Group 2: Pulsed Radiofrequency Ablation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.